Dr. Franco Vizeacoumar awarded a Saskatchewan Cancer Agency Grant

Dr. Franco Vizeacoumar was awarded a 2-year grant from the Saskatchewan Cancer Agency. Title: ‘Characterization of the cell surface protein GPR112 as a potential cancer drug target.’

Apr 2, 2018